drugs Archives - StepChange Innovations Blog

Big pharma´s patent wars in India

Post author:Christian Schumacher
Post published:24/04/2013
Post category:Business Pharma

The Indian Supreme court has rejected a key patent of Novartis for their cancer drug Glivec. The verdict adds to a series of strikes against multinational pharmaceutical companies to gain patent rights in India, potentially one of the biggest pharmaceutical markets in the world.

Indian government forces Bayer to accept generic Nexavar competition – FiercePharma

Post author:Christian Schumacher
Post published:13/03/2012
Post category:Pharma

India has invoked its compulsory licensing rules for the first time to make and sell a version of Bayer's cancer drug Nexavar despite the fact that Nexavar is still on patent. We think this is quite a significant development. What does it mean for ROI of big pharma companies R&D ? What does it mean for IP integrity for doing business in India ?